# Nanjing Chamlion Laser Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanjing-chamlion-laser-technology-co

- Industry: Healthcare IT
- Headquarters: Nanjing, China
- Website: www.chamlion.com
- Total disclosed funding: $83M
- Latest round: Series B (May 27, 2025)
- Investors on record: 6

## About

Established in 2017 and based in Nanjing, China, Nanjing Chamlion Laser Technology Co., Ltd. operates as a precision stamping dies and stamped parts manufacturer that provides dental 3D printing digital solutions. The company was established by the Additive Manufacturing Institute of Nanjing University of Aeronautics and Astronautics. It has more than 260 cloud factories and access to 27 countries worldwide, including the United States, Canada and Italy. In December 2017, it promoted the first generation of products M200. In April 2019, the company established a subsidiary called Anhui Zhumeng 3D Intelligent Manufacturing Research Institute Co., Ltd. In April 2023, it raised CNY 238 million in series B funding led by 3H Health Investment Management (Hong Kong) Limited. The company also cooperates with many universities at home and abroad to establish internship bases for college students. In May 2025, Nanjing Chamlion Laser Technology Co., Ltd. raised CNY 20 million in pre-series A funding from new investors Fortune Capital and GTJA Investment Group. Its products and services are divided into four series, which include printing services, equipment, software and printing materials. The company provides denture 3D model design, 3D printing and post-processing services. Software includes dental intelligent design software and LionSky intelligent slicing software. Printing materials include metal materials and non-metallic materials, such as titanium alloy and resin liquid. At present, the cumulative installed capacity of the company's metal 3D printer exceeds 1,000 units, and 80,000 metal dental crowns. The company’s revenue is generated by providing a one-stop dental 3D printing digital solution.

## Funding rounds

- Series B, May 27, 2025, $28M — GTJA Investment Group, Fortune Capital
- Series B, Apr 18, 2023, $34M — Vertex Ventures China, Zhencheng Capital, Taihe Capital, 3H Health Investment
- Series A, Jul 5, 2022, $21M — Zhencheng Capital

## Investors

- Zhencheng Capital (https://capitalatlas.ai/funds/zhencheng-capital) — Series A, Series B
- Vertex Ventures China (https://capitalatlas.ai/funds/vertex-ventures-china) — Series B
- Taihe Capital — Series B
- 3H Health Investment (https://capitalatlas.ai/funds/3h-health-investment) — Series B
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series B
- Fortune Capital — Series B